David Lloyd: Thanks Lisa Murphy for Your Leadership
David Lloyd, Chief Executive Officer at National Heart Foundation of Australia, reposted from Lisa Murphy and Stroke Foundation on LinkedIn:
”Great colleagues and friends in complete alignment on our mission – Heart Foundation and Stroke Foundation.
Thanks Lisa Murphy for your leadership in helping to bring our two organisations closer together than ever before, to better serve our overlapping patient communities.”
Quoting Lisa Murphy‘s post:
”Stronger Together”
Quoting Stroke Foundation‘s post:
”We are proud to announce the signing of a new collaborative agreement between Stroke Foundation and Heart Foundation.
The agreement commits both organisations to continue supporting the work of the National Hypertension Taskforce, including the development of updated clinical guidelines on lipid and blood pressure management, joint projects and evidence-based position statements.
High blood pressure (hypertension) is the leading risk factor for death in Australia, with around one in three Australians living with the condition.
With only 32% of Australians currently achieving adequate blood pressure control, collaborative sector approach comes at a crucial time to improve blood pressure control to 70% by 2030 in Australia.
Achieving better management of blood pressure and lipids will mean fewer heart attacks, fewer strokes, and healthier lives for Australians across the country.
This agreement demonstrates the ongoing commitment of Stroke Foundation and Heart Foundation to work together towards a common goal: better cardiovascular health for all Australians!
(photo caption: Stroke Foundation CEO Lisa Murphy and Heart Foundation CEO David Lloyd)”

Stay updated with Hemostasis Today.
-
Nov 15, 2026, 16:29Jean-Jacques Kiladjian: 20 Years of Interferon-Alpha Research in Myeloproliferative Neoplasms
-
Nov 15, 2026, 16:21Sukanto Paul: Why Platelet Transfusion Is Generally Avoided in TTP
-
Nov 15, 2026, 16:14Ahmad G. Alzahrani: Major Bleeding and Anticoagulant Reversal
-
Nov 15, 2026, 16:05Sabine Eichinger: Is Recurrence Risk After Provoked VTE Really Low?
-
Nov 15, 2026, 15:53Nicolas Schommer: The Seed and Soil Hypothesis of NET-Mediated Inflammation
-
Nov 15, 2026, 15:36Giovanni Merlino: Targeting LDL-C to Prevent Recurrent Stroke
-
Nov 15, 2026, 15:33Riitta Lassila: From Helsinki to ISTH 2027 Advancing Thrombosis Research
-
Nov 15, 2026, 15:30Andreas Calatzis: Can Protein C and Plasma Overcome Fibrinolysis Resistance in Sepsis?
-
Nov 15, 2026, 15:25Hussnain Javaid: Thalassaemia 2026 New Therapies Transforming UK Practice